[HTML][HTML] Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC Cancer, 2023 - europepmc.org
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
[HTML][HTML] Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC Cancer, 2023 - ncbi.nlm.nih.gov
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis.
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC …, 2023 - search.ebscohost.com
Background: Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC Cancer, 2023 - profiles.wustl.edu
Background: Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
[PDF][PDF] Please let us know how this document benefits you.
S Kanters, G Ball, B Kahl, A Wiesinger… - core.ac.uk
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. How‑ever, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. How‑ever, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC …, 2023 - search.proquest.com
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: A systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - 2023 - digitalcommons.wustl.edu
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. How‑ever, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. How‑ever, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
[HTML][HTML] Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger… - BMC …, 2023 - bmccancer.biomedcentral.com
Patients with follicular lymphoma (FL) can have high response rates to early lines of
treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines of …
treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines of …